Andreas Caduff has been a driving force in the development of non-invasive, wearable sensor technologies for in vivo monitoring and involved physiological processes. Particularly, he has introduced multisensor based monitoring systems for wearable physiological monitoring. This has led to several dozen publications and numerous patents. He held various positions in the pharmaceutical and medical device industry. In his previous position he was serving as CTO of Solianis, a company focusing on multisensor based non-invasive glucose monitoring. In 2011, he founded Biovotion AG, an organisation developing specialised non-invasive physiological monitoring and digital health solutions, where h...